Board of Directors

Jarl has a long experience from leading positions from several industries. Among other position he has worked as CEO at Anticimex International AB during 2015 - 2022, at Loomis Inc and Loomis AB between 2009 - 2015. Jarl is currently the chairman of the board for Anticimex Group AB and for SNFL Ltd. Jarl is member of the board for Guardian Pest Control in China, Melker Schörling AB and IVC Evidensia.

Ali is a Partner at EQT and has been with the company since 2013. He is a member of the Technology sector team where he is leading the investment efforts in the Nordic region. Ali has been involved in numerous investments across the technology and services sectors and currently sits on the board of directors of Envirotainer, IVC Evidensia and Zooplus. Prior to joining EQT, Ali worked at Morgan Stanley in London and Stockholm. Ali holds a BSc in Economics from Stockholm School of Economics.

Simon is a Director at EQT and has been with the company since 2015. He is a member of the Services sector team and has been involved in a number of investments, including but not limited to Envirotainer, Schülke and Bluestep. Prior to joining EQT, Simon worked at Morgan Stanley in London and Stockholm. Simon holds a BSc in Economics from University of Gothenburg, a Master of Finance from University of Cambridge and has studied Industrial Engineering and Management at Chalmers University of Technology.

Camilla Macapili Languille is the Head of Life Sciences for Mubadala, where she oversees the firm’s private equity investments in healthcare globally.  She currently serves on the boards of PCI Pharma, Evotec, Envision Pharma Group, and Citeline, and serves as a member of the Mubadala Direct Investments Investment Committee.  Prior to joining Mubadala in 2013, Camilla worked for Daiwa Capital and Société Générale in Paris, for Virgin Group in London, and for JPMorgan in London and New York.  Camilla holds a Bachelor’s degree (summa cum laude) in Economics & Political Science from Columbia University in New York. 

Andreas has been working for Envirotainer for 15 years, his current role is as Quality Engineer. He is also the chairman of the union club (Unionenklubben) at Envirotainer.

Tom is a member of the Industrials sector team and the Nordic regional team at Cinven at has been with the company since 2017. He has been involved in a number of transactions, including Arxada (formerly LSI) and Envirotainer.
Prior to joining Cinven, Tom was an Investment Banking Analyst at Deutsche Bank in the EMEA Industrials team.
Tom has a BSc and MSc in Industrial Engineering and Management from the Royal Institute of Technology and a BSc in Business and Economics from the Stockholm School of Economics.

Wes Wheeler is President of UPS Healthcare, a $10 Billion Division of UPS.  Prior to this role Wes was the CEO of Marken, LLP, a leading clinical supply chain service provider.  He managed Marken as a PE-owned company for six years before selling it to UPS in 2016.

Wes also serves as the Chairman of the Board for Bushu Pharmaceuticals, a Japan-based contract manufacturing company.

Wes joined GlaxoSmithKline in 1989 and worked for 12 years as SVP, Global Manufacturing & Supply. He has since served as CEO / President at Patheon, Valeant and DSM Pharmaceuticals. Prior to joining GSK, he worked for 12 years at ExxonMobil.

Wes holds a BS degree in Mechanical Engineering from Worcester Polytechnic Institute in addition to an MBA.

Linzell Harris is the recently retired senior vice president of Global Supply Chain and Strategy for AstraZeneca,  with overall responsibility for the development and execution of the end-to-end supply chain platform and product supply strategies.  

Prior to joining AstraZeneca, Linzell held the role of Senior Vice President, Global Supply Chain for TEVA Pharmaceuticals. Before TEVA, he served as Head of Global Operations for Godiva Chocolatier and as a member of Godiva’s Executive Leadership team reporting to the CEO and President. Additionally, Linzell has worked in Senior Management roles at Johnson and Johnson, Pfizer, Warner Lambert and Baxter Healthcare. 

Linzell earned a BS in Mathematics from the US Naval Academy in Annapolis, MD. He has completed graduate and executive studies at Villanova, Michigan State, Columbia and Harvard Universities.